TCGA data were used to analyze the role of MARCH5 expression in HCC patient outcomes, which showed that MARCH5 mRNA expression was positively correlated with patient survival (Fig. 1c). This evidence concerns the gene MARCHF5 and hepatocellular carcinoma.